DSE Corporate Events, Board Meetings and Dividends Calendar

Date	Stock	Title	Expect
10 Nov	KBPPWBIL	LR 19(1)	C 10% 2025
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 3:00 PM to consider, among others, annual audited financial statements of the Company for the year ended June 30, 2026.
10 Nov	ATLASBANG	LR 16(1)	Annual -0.22
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.
10 Nov	ATLASBANG	LR 19(1)	C 5% 2020
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 3:00 PM to consider, among others, annual audited financial statements of the Company for the year ended June 30, 2026.
10 Nov	SQUARETEXT	LR 16(1)	Annual 0.51
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 4:00 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.
10 Nov	SQURPHARMA	LR 16(1)	ENQ1 7.81
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.
10 Nov	MJLBD	LR 16(1)	ENQ1 2.76
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.
10 Nov	DOMINAGE	LR 19(1)	C 0.35% 2025
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 4:00 PM to consider, among others, annual audited financial statements of the Company for the year ended June 30, 2026.
10 Nov	EHL	LR 16(1)	ENQ1 1.67
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 3:30 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.
10 Nov	MONNOFABR	LR 16(1)	ENQ1 0.01
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 4:00 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.
10 Nov	INTRACO	LR 19(1)	C 1.25% 2025
The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on November 10, 2026 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2026.
10 Nov	SAMATALETH	LR 16(1)	ENQ1 -0.01
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 4:30 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2025.
10 Nov	APEXTANRY	Record Date
(Cont. news of APEXTANRY): Record date: 10.11.2026. The Company has also reported EPS of Tk. (20.55), NAV per share of Tk. 192.99 and NOCFPS of Tk. (13.53) for the year ended June 30, 2026 as against Tk. (14.62), Tk. 30.19 and Tk. 2.58 respectively for the year ended June 30, 2025. (end)
10 Nov	WMSHIPYARD	LR 16(1)	ENQ3 -0.02
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 4:00 PM to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.
10 Nov	BEACONPHAR	Record Date
The Board of Directors has recommended 11% Cash Dividend for the year ended June 30, 2026. Date of AGM: 13.12.2026, Time: 11:00 AM, Venue: Digital Platform subject to approval from BSEC. Record Date: 10.11.2026. The Company has also reported EPS of Tk. 8.41, NAV per share of Tk. 35.83 and NOCFPS of Tk. 9.68 for the year ended June 30, 2026 as against Tk. 4.10, Tk. 28.86 and Tk. 6.93 respectively for the year ended June 30, 2025. (cont.1)
10 Nov	SQURPHARMA	Buy
Mrs. Ratna Patra, a Directors of the Company, has expressed her intention to buy 1,750,000 shares of the company at the prevailing market price in both the Public and Block Markets through Dhaka Stock Exchange PLC. (DSE) within next 30 working days.
10 Nov	MONOSPOOL	BMRE
(Cont. News of MONOSPOOL): as against EPS of Tk. 3.27, NAV per share of Tk. 39.18 and NOCFPS of Tk. (3.64) for the year ended June 30, 2025. Disclosure for recommending stock dividend: a) The amount representing 10% Stock dividend will be utilized for BMRE components and as working capital of the company; b)The company has declared such stock dividend or bonus shares out of the accumulated profit or retained earnings; (cont.3)
10 Nov	MONOSPOOL	Dividend	C 5% 2025
The Board of Directors has recommended 10% Cash Dividend for all General Shareholders excluding Sponsors and Directors and 10% Stock Dividend to all Shareholders subject to approval of BSEC for the year ended June 30, 2026. Total no. of shares of the company is 3,92,20,866. General Shareholders are holding 2,40,04,659 share. Tk. 2,40,04,659/- will be paid to them as 10% cash dividend. (cont.1)
10 Nov	BBS	Financials	Q1\|G -62.7%
(Q1 Un-audited): EPS was Tk. (0.24) for July-September 2026 as against Tk. (0.23) for July-September 2025. NOCFPS was Tk. 0.01 for July-September 2026 as against Tk. (0.02) for July-September 2025. NAV per share was Tk. 9.51 as on September 30, 2026 and Tk. 10.69 as on June 30, 2026. Reasons for deviation: NOCFPS has stood Tk.0.01 for the period ended on 30th September, 2026 as against Tk. (0.02) for the period ended on 30th September, 2025 due to decreasing the payment to the Creditors. (cont.)
10 Nov	MAGURAPLEX	BMRE
(Cont. News of MAGURAPLEX): The Company has also reported EPS of Tk. 2.23, NAV per share of Tk. 75.92 and NOCFPS of Tk. 0.51 for the year ended June 30, 2026 as against EPS of Tk. 3.60, NAV per share of Tk. 74.79 and NOCFPS of Tk. 0.58 for the year ended June 30, 2025. Disclosure for recommending stock dividend: a) The amount representing 25% Stock dividend will be retained/utilized for purchase of BMRE components and as working capital of the company and to meet regulatory requirements to raise (cont.2)
10 Nov	ORIONINFU	Record Date
(Cont. News of ORIONINFU): Record Date: November 29, 2026. The Company has also reported EPS of Tk. 1.43, NAV per share of Tk. 16.27 and NOCFPS of Tk. 2.97 for the year ended June 30, 2026 as against Tk. 1.72, Tk. 16.02 and Tk. 1.30 respectively for the year ended June 30, 2025. (end)
10 Nov	ORIONINFU	AGM
The Board of Directors has recommended 2% Cash Dividend for General Shareholders only excluding Sponsor Shareholders for the year ended June 30, 2026. The Sponsor Shareholders hold 8,268,400 shares and the General Shareholders hold 12,091,360 shares, totaling 20,359,760 shares of the Company. The cash dividend payable to the General Shareholders amounts to BDT 24,18,272.00. Date of AGM: December 21, 2026 at 2:00 p.m., Venue: Digital Platform. (cont.)
10 Nov	ORIONINFU	Dividend	C 20% 2025
The Board of Directors has recommended 2% Cash Dividend for General Shareholders only excluding Sponsor Shareholders for the year ended June 30, 2026. The Sponsor Shareholders hold 8,268,400 shares and the General Shareholders hold 12,091,360 shares, totaling 20,359,760 shares of the Company. The cash dividend payable to the General Shareholders amounts to BDT 24,18,272.00. Date of AGM: December 21, 2026 at 2:00 p.m., Venue: Digital Platform. (cont.)
10 Nov	ORIONPHARM	AGM
The Board of Directors has recommended No Dividend for the year ended June 30, 2026. Date of AGM: December 21, 2026 at 4:00 p.m. Date of EGM: December 21, 2026 at 4:45 p.m. Venue: The 61st AGM and EGM will be held on Hybrid Platform at Sky View Restaurant, Novo Tower (15th Floor), 270 Tejgaon I/A, Dhaka 1208. Record Date: November 29, 2026. The Company has also reported Consolidated EPS of Tk. (1.93), Consolidated NAV per share (cont.1)
10 Nov	ORIONPHARM	EGM
The Board of Directors has recommended No Dividend for the year ended June 30, 2026. Date of AGM: December 21, 2026 at 4:00 p.m. Date of EGM: December 21, 2026 at 4:45 p.m. Venue: The 61st AGM and EGM will be held on Hybrid Platform at Sky View Restaurant, Novo Tower (15th Floor), 270 Tejgaon I/A, Dhaka 1208. Record Date: November 29, 2026. The Company has also reported Consolidated EPS of Tk. (1.93), Consolidated NAV per share (cont.1)
10 Nov	ORIONPHARM	Dividend	C 10% 2024
The Board of Directors has recommended No Dividend for the year ended June 30, 2026. Date of AGM: December 21, 2026 at 4:00 p.m. Date of EGM: December 21, 2026 at 4:45 p.m. Venue: The 61st AGM and EGM will be held on Hybrid Platform at Sky View Restaurant, Novo Tower (15th Floor), 270 Tejgaon I/A, Dhaka 1208. Record Date: November 29, 2026. The Company has also reported Consolidated EPS of Tk. (1.93), Consolidated NAV per share (cont.1)
10 Nov	ORIONPHARM	Record Date
The Board of Directors has recommended No Dividend for the year ended June 30, 2026. Date of AGM: December 21, 2026 at 4:00 p.m. Date of EGM: December 21, 2026 at 4:45 p.m. Venue: The 61st AGM and EGM will be held on Hybrid Platform at Sky View Restaurant, Novo Tower (15th Floor), 270 Tejgaon I/A, Dhaka 1208. Record Date: November 29, 2026. The Company has also reported Consolidated EPS of Tk. (1.93), Consolidated NAV per share (cont.1)
10 Nov	BBSCABLES	Financials	Q1\|G -27.4%
(Q1 Un-audited): EPS was Tk. (1.29) for July-September 2026 as against Tk. (0.86) for July-September 2025. NOCFPS was Tk. 0.06 for July-September 2026 as against Tk. 0.34 for July-September 2025. NAV per share was Tk. 21.64 as on September 30, 2026 and Tk. 22.93 as on June 30, 2026. Reasons for deviation: EPS has decreased comparing last period due to decreases of revenue, Bank Interest rate increase, USD Fluctuation, Raw Materials price Increase. (cont.)
10 Nov	RENWICKJA	Financials	Q1\|G -39.2%
(Q1 Un-audited): EPS was Tk. (2.70) for July-September 2026 as against Tk. (2.90) for July-September 2025. NOCFPS was Tk. (3.32) for July-September 2026 as against Tk. (3.81) for July-September 2025. NAV per share was Tk. 6023.12 as on September 30, 2026 and Tk. 6025.83 as on June 30, 2026. (cont.)
10 Nov	ISNLTD	Financials	Q1\|G +72.1%
(Q1 Un-audited): EPS was Tk. (0.03) for July-September 2026 as against Tk. (0.01) for July-September 2025. NOCFPS was Tk. 0.35 for July-September 2026 as against Tk. 0.45 for July-September 2025. NAV per share was Tk. 1.88 as on September 30, 2026 and Tk. 1.91 as on June 30, 2026.
10 Nov	MEGHNAPET	LR 16(1)	Annual -0.21
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026
10 Nov	MEGCONMILK	LR 16(1)	Annual -1.61
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 2:35 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.
10 Nov	ECABLES	LR 16(1)	Annual -1.25
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 3:00 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.
10 Nov	ECABLES	LR 19(1)	C 2% 2024
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2026 at 3:00 PM to consider, among others, annual audited financial statements of the Company for the year ended June 30, 2026.